Beaton Management Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.42M | Hold |
23,369
| – | – | 0.63% | 48 |
|
|
2025
Q4 | $1.26M | Buy |
23,369
+700
| +3% | +$33.7K | 0.56% | 51 |
|
|
2025
Q3 | $1.02M | Buy |
22,669
+250
| +1% | +$11.7K | 0.46% | 57 |
|
|
2025
Q2 | $1.04M | Sell |
22,419
-100
| -0.4% | -$4.91K | 0.51% | 59 |
|
|
2025
Q1 | $1.37M | Buy |
22,519
+1,395
| +7% | +$81.3K | 0.71% | 48 |
|
|
2024
Q4 | $1.2M | Buy |
21,124
+700
| +3% | +$39.1K | 0.6% | 54 |
|
|
2024
Q3 | $1.06M | Hold |
20,424
| – | – | 0.53% | 56 |
|
|
2024
Q2 | $848K | Hold |
20,424
| – | – | 0.46% | 61 |
|
|
2024
Q1 | $1.11M | Buy |
20,424
+500
| +3% | +$25.5K | 0.6% | 50 |
|
|
2023
Q4 | $1.02M | Sell |
19,924
-134
| -0.7% | -$7.03K | 0.61% | 52 |
|
|
2023
Q3 | $1.16M | Sell |
20,058
-100
| -0.5% | -$6.13K | 0.76% | 44 |
|
|
2023
Q2 | $1.29M | Buy |
20,158
+500
| +3% | +$33.5K | 0.82% | 38 |
|
|
2023
Q1 | $1.36M | Hold |
19,658
| – | – | 0.92% | 35 |
|
|
2022
Q4 | $1.41M | Hold |
19,658
| – | – | 0.95% | 33 |
|
|
2022
Q3 | $1.4M | Hold |
19,658
| – | – | 1.06% | 31 |
|
|
2022
Q2 | $1.51M | Hold |
19,658
| – | – | 1.07% | 32 |
|
|
2022
Q1 | $1.44M | Buy |
19,658
+50
| +0.3% | +$3.36K | 0.89% | 38 |
|
|
2021
Q4 | $1.22M | Buy |
19,608
+220
| +1% | +$12.9K | 0.73% | 43 |
|
|
2021
Q3 | $1.15M | Buy |
19,388
+755
| +4% | +$49.7K | 0.76% | 40 |
|
|
2021
Q2 | $1.25M | Hold |
18,633
| – | – | 0.79% | 43 |
|
|
2021
Q1 | $1.18M | Hold |
18,633
| – | – | 0.81% | 43 |
|
|
2020
Q4 | $1.16M | Sell |
18,633
-200
| -1% | -$12.3K | 0.85% | 38 |
|
|
2020
Q3 | $1.14M | Sell |
18,833
-280
| -1% | -$16.9K | 0.94% | 36 |
|
|
2020
Q2 | $1.12M | Hold |
19,113
| – | – | 1% | 38 |
|
|
2020
Q1 | $1.06M | Buy |
19,113
+750
| +4% | +$45.8K | 1.07% | 34 |
|
|
2019
Q4 | $1.18M | Buy |
18,363
+600
| +3% | +$34.4K | 0.92% | 36 |
|
|
2019
Q3 | $901K | Sell |
17,763
-880
| -5% | -$41.4K | 0.73% | 45 |
|
|
2019
Q2 | $845K | Sell |
18,643
-786
| -4% | -$36.6K | 0.7% | 47 |
|
|
2019
Q1 | $927K | Sell |
19,429
-1,290
| -6% | -$64.3K | 0.8% | 43 |
|
|
2018
Q4 | $1.08M | Sell |
20,719
-1,500
| -7% | -$80.6K | 1.06% | 31 |
|
|
2018
Q3 | $1.38M | Sell |
22,219
-410
| -2% | -$24.3K | 1.14% | 30 |
|
|
2018
Q2 | $1.25M | Sell |
22,629
-650
| -3% | -$35.1K | 1.12% | 29 |
|
|
2018
Q1 | $1.47M | Hold |
23,279
| – | – | 1.36% | 22 |
|
|
2017
Q4 | $1.43M | Buy |
23,279
+300
| +1% | +$18.8K | 1.29% | 24 |
|
|
2017
Q3 | $1.47M | Hold |
22,979
| – | – | 1.38% | 23 |
|
|
2017
Q2 | $1.28M | Buy |
+22,979
| New | +$1.25M | 1.27% | 22 |
|
Other funds holding BMY
VCM
VPM
Beaton Management Company's BMY Position: Q1 2026 in Review
Beaton Management Company held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 23,369 shares worth $1.42M. The position accounts for 0.63% of the portfolio, ranked #48.
Beaton Management Company first reported a position in BMY in Q2 2017 and has held it in 36 quarters since. The position peaked at $1.51M in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Beaton Management Company held 23,369 shares of Bristol-Myers Squibb worth $1.42M as of Q1 2026.
- Beaton Management Company left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.63% of Beaton Management Company's portfolio in Q1 2026, its #48 holding.
- Beaton Management Company first reported a position in Bristol-Myers Squibb in Q2 2017 and has held it in 36 quarters since.
- Beaton Management Company's Bristol-Myers Squibb position peaked at $1.51M in Q2 2022.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Beaton Management Company's 13F filing for Q1 2026, filed 12 May 2026.